WallStreetZenWallStreetZen

NASDAQ: APLT
Applied Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for APLT

Based on 4 analysts offering 12 month price targets for Applied Therapeutics Inc

Min Forecast
$1.50+281.68%
Avg Forecast
$4.13+949.62%
Max Forecast
$8.00+1,935.62%

Should I buy or sell APLT stock?

Based on 4 analysts offering ratings for Applied Therapeutics Inc.

Buy
Strong Buy
1 analysts 25%
Buy
1 analysts 25%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APLT stock forecasts and price targets.

APLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-20
lockedlocked$00.00+00.00%2024-12-02
lockedlocked$00.00+00.00%2024-11-29Find Out Why
lockedlocked$00.00+00.00%2024-11-29Find Out Why

1 of 1

Forecast return on equity

Is APLT forecast to generate an efficient return?

Company
1,055.5%
Industry
146.26%
Market
80.85%
APLT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is APLT forecast to generate an efficient return on assets?

Company
694.07%
Industry
36.38%
APLT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

APLT earnings per share forecast

What is APLT's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.74
Avg 2 year Forecast
-$0.55
Avg 3 year Forecast
$2.42

APLT revenue forecast

What is APLT's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$10.9M+2,295.6%
Avg 2 year Forecast
$54.3M+11,834.07%
APLT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

APLT revenue growth forecast

How is APLT forecast to perform vs Biotechnology companies and vs the US market?

Company
905.28%
Industry
64.61%
Market
10.18%
APLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APLT$0.39$4.13+949.62%Buy
ARMP$1.53$7.00+357.52%Buy
IMMX$2.02$7.00+246.53%Buy
RPTX$1.32$4.50+240.91%Strong Buy
DTIL$5.23$47.00+798.66%Buy
View Top Biotech Stocks

Applied Therapeutics Stock Forecast FAQ

Is Applied Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: APLT) stock is to Buy APLT stock.

Out of 4 analysts, 1 (25%) are recommending APLT as a Strong Buy, 1 (25%) are recommending APLT as a Buy, 2 (50%) are recommending APLT as a Hold, 0 (0%) are recommending APLT as a Sell, and 0 (0%) are recommending APLT as a Strong Sell.

If you're new to stock investing, here's how to buy Applied Therapeutics stock.

What is APLT's earnings growth forecast for 2025-2027?

(NASDAQ: APLT) Applied Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Applied Therapeutics's earnings in 2025 is -$105,624,000.On average, 2 Wall Street analysts forecast APLT's earnings for 2025 to be -$104,765,889, with the lowest APLT earnings forecast at -$116,091,931, and the highest APLT earnings forecast at -$93,439,847. On average, 1 Wall Street analyst forecast APLT's earnings for 2026 to be -$77,866,539, with the lowest APLT earnings forecast at -$77,866,539, and the highest APLT earnings forecast at -$77,866,539.

In 2027, APLT is forecast to generate $342,612,773 in earnings, with the lowest earnings forecast at $342,612,773 and the highest earnings forecast at $342,612,773.

What is APLT's revenue growth forecast for 2025-2026?

(NASDAQ: APLT) Applied Therapeutics's forecast annual revenue growth rate of 905.28% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.18%.

Applied Therapeutics's revenue in 2025 is $455,000.On average, 2 Wall Street analysts forecast APLT's revenue for 2025 to be $1,543,173,233, with the lowest APLT revenue forecast at $1,415,755,260, and the highest APLT revenue forecast at $1,670,591,207.

In 2026, APLT is forecast to generate $7,687,551,062 in revenue, with the lowest revenue forecast at $7,687,551,062 and the highest revenue forecast at $7,687,551,062.

What is APLT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: APLT) forecast ROA is 694.07%, which is higher than the forecast US Biotechnology industry average of 36.38%.

What is APLT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year APLT price target, the average APLT price target is $4.13, with the highest APLT stock price forecast at $8.00 and the lowest APLT stock price forecast at $1.50.

On average, Wall Street analysts predict that Applied Therapeutics's share price could reach $4.13 by Dec 20, 2025. The average Applied Therapeutics stock price prediction forecasts a potential upside of 949.62% from the current APLT share price of $0.39.

What is APLT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: APLT) Applied Therapeutics's current Earnings Per Share (EPS) is -$0.76. On average, analysts forecast that APLT's EPS will be -$0.74 for 2025, with the lowest EPS forecast at -$0.82, and the highest EPS forecast at -$0.66. On average, analysts forecast that APLT's EPS will be -$0.55 for 2026, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at -$0.55. In 2027, APLT's EPS is forecast to hit $2.42 (min: $2.42, max: $2.42).

What is APLT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: APLT) forecast ROE is 1,055.5%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.